ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 93 filers reported holding ADMA BIOLOGICS INC in Q2 2021. The put-call ratio across all filers is 5.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,516 | -3.0% | 10,200 | 0.0% | 0.04% | +2.9% |
| Q2 2023 | $37,638 | +11.5% | 10,200 | 0.0% | 0.04% | +12.9% |
| Q1 2023 | $33,762 | -14.7% | 10,200 | 0.0% | 0.03% | -20.5% |
| Q4 2022 | $39,576 | +58.3% | 10,200 | 0.0% | 0.04% | +39.3% |
| Q3 2022 | $25,000 | +19.0% | 10,200 | -1.9% | 0.03% | +27.3% |
| Q2 2022 | $21,000 | +10.5% | 10,400 | 0.0% | 0.02% | +37.5% |
| Q1 2022 | $19,000 | +26.7% | 10,400 | 0.0% | 0.02% | +23.1% |
| Q4 2021 | $15,000 | +25.0% | 10,400 | -1.0% | 0.01% | +18.2% |
| Q3 2021 | $12,000 | -29.4% | 10,500 | 0.0% | 0.01% | -26.7% |
| Q2 2021 | $17,000 | -5.6% | 10,500 | 0.0% | 0.02% | -11.8% |
| Q1 2021 | $18,000 | – | 10,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |